DR Hill

760 total citations
10 papers, 683 citations indexed

About

DR Hill is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, DR Hill has authored 10 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in DR Hill's work include Neuropeptides and Animal Physiology (8 papers), Peptidase Inhibition and Analysis (4 papers) and Receptor Mechanisms and Signaling (3 papers). DR Hill is often cited by papers focused on Neuropeptides and Animal Physiology (8 papers), Peptidase Inhibition and Analysis (4 papers) and Receptor Mechanisms and Signaling (3 papers). DR Hill collaborates with scholars based in United Kingdom, United States and France. DR Hill's co-authors include Colin T. Dourish, W.C. Graham, A. Jon Stoessl, David C. Horwell, Nirmala Suman‐Chauhan, Clare O. Kneen, John C. Hunter, Martyn C. Pritchard, Edward Roberts and Michael Higginbottom and has published in prestigious journals such as Journal of Neuroscience, Brain Research and Trends in Pharmacological Sciences.

In The Last Decade

DR Hill

10 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DR Hill United Kingdom 8 586 425 122 103 100 10 683
Jaroslav H. Boublik United States 15 512 0.9× 370 0.9× 143 1.2× 189 1.8× 66 0.7× 27 791
Jari A Larm Australia 10 435 0.7× 350 0.8× 177 1.5× 43 0.4× 110 1.1× 11 685
T. Bartfai Sweden 12 508 0.9× 489 1.2× 66 0.5× 108 1.0× 102 1.0× 21 770
Öie Nordström Sweden 11 705 1.2× 569 1.3× 76 0.6× 102 1.0× 187 1.9× 14 829
S.D. Iversen United States 8 380 0.6× 197 0.5× 131 1.1× 113 1.1× 56 0.6× 11 472
J A Clark United States 11 431 0.7× 436 1.0× 47 0.4× 150 1.5× 28 0.3× 13 679
L.L. Iversen United States 11 461 0.8× 303 0.7× 38 0.3× 123 1.2× 53 0.5× 14 549
K. Tsuruta Japan 7 458 0.8× 422 1.0× 66 0.5× 76 0.7× 19 0.2× 11 685
Dominique Quarteronet France 8 426 0.7× 306 0.7× 31 0.3× 64 0.6× 73 0.7× 10 563
H Kenneth Kramer United States 16 473 0.8× 394 0.9× 40 0.3× 88 0.9× 20 0.2× 18 703

Countries citing papers authored by DR Hill

Since Specialization
Citations

This map shows the geographic impact of DR Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DR Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DR Hill more than expected).

Fields of papers citing papers by DR Hill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DR Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DR Hill. The network helps show where DR Hill may publish in the future.

Co-authorship network of co-authors of DR Hill

This figure shows the co-authorship network connecting the top 25 collaborators of DR Hill. A scholar is included among the top collaborators of DR Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DR Hill. DR Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hunter, John C., Nirmala Suman‐Chauhan, Ken Meecham, et al.. (1993). [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.. Molecular Pharmacology. 43(4). 595–602. 22 indexed citations
2.
Higginbottom, Michael, et al.. (1993). Conformationally restricted analogues of the potent CCK-B antagonist CI-988. Bioorganic & Medicinal Chemistry. 1(3). 209–217. 7 indexed citations
3.
Higginbottom, Michael, et al.. (1993). Rationally designed ‘dipeptoid’ analogues of cholecystokinin (CCK): C-terminal structure-activity relationships of α-methyl tryptophan derivatives. European Journal of Medicinal Chemistry. 28(1). 47–61. 8 indexed citations
4.
Padia, Janak, et al.. (1993). Synthesis and sar study of novel CCK-B antagonists. Bioorganic & Medicinal Chemistry Letters. 3(12). 2805–2810. 3 indexed citations
5.
Higginbottom, Michael, et al.. (1993). Rationally designed ‘dipeptoid’ analogues of cholecystokinin (CCK): N-terminal structure-affinity relationships of α-methyl-tryptophan derivatives. European Journal of Medicinal Chemistry. 28(1). 37–45. 8 indexed citations
6.
Hill, DR, David C. Horwell, John C. Hunter, et al.. (1993). Synthesis of a potent and selective non-peptide CCK-B/gastrin receptor antagonist tritiated ligand.. Bioorganic & Medicinal Chemistry Letters. 3(5). 885–888. 11 indexed citations
7.
Hill, DR, et al.. (1990). Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125I-Bolton Hunter CCK-8 and 3H-MK-329. Journal of Neuroscience. 10(4). 1070–1081. 136 indexed citations
8.
Stoessl, A. Jon & DR Hill. (1990). Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H]senktide. Brain Research. 534(1-2). 1–7. 68 indexed citations
9.
Dourish, Colin T. & DR Hill. (1987). Classification and function of CCK receptors. Trends in Pharmacological Sciences. 8(6). 207–208. 107 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaroslav H. Boublik Breakdown of academic impact, for papers by Jari A Larm Breakdown of academic impact, for papers by T. Bartfai Breakdown of academic impact, for papers by Öie Nordström Breakdown of academic impact, for papers by S.D. Iversen Breakdown of academic impact, for papers by J A Clark Breakdown of academic impact, for papers by L.L. Iversen Breakdown of academic impact, for papers by K. Tsuruta Breakdown of academic impact, for papers by Dominique Quarteronet Breakdown of academic impact, for papers by H Kenneth Kramer
Rankless by CCL
2026